Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Down 91.5% in June

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 23,325 shares, a decline of 91.5% from the June 15th total of 273,134 shares. Approximately 1.2% of the shares of the stock are short sold. Based on an average daily volume of 95,314 shares, the short-interest ratio is presently 0.2 days.

Arcadia Biosciences Trading Up 1.4%

Arcadia Biosciences stock traded up $0.01 during mid-day trading on Friday, hitting $0.68. The company’s stock had a trading volume of 44,798 shares, compared to its average volume of 254,295. Arcadia Biosciences has a 1 year low of $0.63 and a 1 year high of $6.71. The stock’s fifty day moving average is $0.89 and its two-hundred day moving average is $1.52.

Arcadia Biosciences (NASDAQ:RKDA) last posted its earnings results on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). The business had revenue of $1.10 million during the quarter, compared to analysts’ expectations of $1.60 million. Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%.

Analysts Set New Price Targets

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.